A new drug application seeking the approval of fruquintinib for use in the treatment of patients with refractory metastatic colorectal cancer has been submitted to the FDA.
Solid Tumor benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Executive Director and Chief Executive Officer
Okay, thank you. This is Christian Hogg, CEO of HUTCHMED. And today, we welcome everybody to this Fiscal Year 2020 Results and Business Update Presentation.
On the line I also have Dr. Wei-guo Su, our Chief Scientific Officer and Head of Research and Development; I have Johnny Cheng, our Chief Financial Officer; and I have Dr. Marek Kania, our Chief Medical Officer in the U.S. and Head of our International operations.
What I m planning to do today is, given this is an hour-long session, is spend about 30 minutes 25 minutes to 30 minutes on the presentation. I ll go through it relatively quickly as it s all fairly well laid out in our announcement that s just been out for an hour or so and then I ll leave the second half of the hour for Q&A and that s an opportunity for the broader team that we have here to answer any questions that you might have.